Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Stanford University
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Thomas Jefferson University
Dana-Farber Cancer Institute
University of Rochester
Mayo Clinic
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
University of Illinois at Chicago
Case Comprehensive Cancer Center
Instituto Nacional de Cancer, Brazil
Melbourne Health
University of Liege
Celyad Oncology SA